肝细胞生长因子赋予小梁网干细胞抗逆性并旁分泌保护小梁网细胞
本研究比较了人小梁网干细胞(TMSCs)与小梁网细胞(TM cells)对TGF-β2的不同反应,发现TMSCs存活更好、线粒体功能更佳且氧化应激和纤维化标记更低。RNA测序和细胞因子分析显示TMSCs及其分泌组中HGF显著富集,TMSC分泌组和HGF可减轻TM细胞对TGF-β2的氧化和纤维化反应,而HGF受体抑制剂可消除此保护作用。
要点
- TMSCs比TM细胞对TGF-β2诱导的氧化应激和纤维化更具抵抗力。
- TMSC分泌组和HGF可保护TM细胞免受TGF-β2损伤,HGFI可阻断该效应。
- HGF是TMSCs内在抗逆性和旁分泌保护的关键但部分介质。
核心结论
- TMSC分泌组和HGF是青光眼无细胞疗法的有前景候选者。
- HGF赋予TMSCs内在抗逆性,并作为其保护TM细胞的关键但部分介质。
研究设计与样本
- 以人TMSCs和TM细胞为对象,给予TGF-β2并分别联合抗氧化剂N-乙酰半胱氨酸、TMSC分泌组、HGF或HGF受体抑制剂处理。
- 采用MTT法检测细胞活力,CellROX和C11-BODIPY分别检测活性氧和脂质过氧化,TMRM评估线粒体膜电位。
- 通过免疫荧光和Western blot评估纤维化标记(纤连蛋白、α-SMA、CTGF),RNA测序比较转录谱,细胞因子阵列比较TMSC分泌组与TM细胞分泌组。
- 统计采用t检验或ANOVA后Tukey多重比较,显著性定义为P < 0.05。
主要发现
- 与TM细胞相比,TMSCs在TGF-β2处理后表现出更高的存活率、更好的线粒体功能以及更低的活性氧、脂质过氧化和纤维化标记表达。
- N-乙酰半胱氨酸可部分阻止TGF-β2对TM细胞的作用。
- RNA测序和细胞因子分析显示TMSCs和TMSC分泌组中HGF显著富集。
- TMSC分泌组和HGF显著降低TM细胞对TGF-β2的氧化和纤维化反应,而HGF受体抑制剂消除了这种保护作用。
关键数值与推荐
- 细胞活力采用MTT法评估。
- 活性氧采用CellROX检测,脂质过氧化采用C11-BODIPY检测。
- 线粒体膜电位采用TMRM评估。
- 纤维化标记(纤连蛋白、α-SMA、CTGF)通过免疫荧光染色和Western blot评估。
- 统计学显著性定义为P < 0.05。
临床怎么用
- TMSC分泌组和HGF可能作为青光眼无细胞治疗的候选策略。
- HGF对TM细胞的保护作用是部分性的,提示其他因子也参与TMSC的旁分泌保护。
局限性
- HGF仅部分介导TMSCs对TM细胞的保护作用,存在其他未明确因子。
- 研究为体外细胞实验,尚未在体内或临床中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We have reported that trabecular meshwork stem cells (TMSCs) are effective for trabecular meshwork (TM) regeneration. This study aims to investigate different responses of TMSCs and TM cells to TGF-β2 and protective factors in TMSCs. METHODS: Human TMSCs and TM cells were exposed to TGF-β2 with or without antioxidant N-acetylcysteine, TMSC-derived secretome (TMSC-Scr), hepatocyte growth factor (HGF), or HGF receptor inhibitor (HGFI). Cell viability was assessed by the MTT assay. Intracellular reactive oxygen species (ROS) and lipid peroxidation were measured using CellROX and C11-BODIPY, respectively. Mitochondrial membrane potential was assessed using tetramethylrhodamine methyl ester (TMRM). Fibrotic markers (fibronectin, α-SMA, CTGF) were evaluated by immunofluorescent staining and Western blotting. RNA sequencing was performed to compare transcriptional profiles between TMSCs and TM cells. A cytokine array was used to compare TMSC-Scr and TM-Scr. A t-test or ANOVA followed by Tukey's multiple comparisons test was used for statistical analysis, with significance defined as P < 0.05. RESULTS: Compared with TM cells, TMSCs exhibited greater survival, better-preserved mitochondrial function, and lower levels of ROS, lipid peroxidation, and fibrotic marker expression after TGF-β2 treatment. N-acetylcysteine partially prevented TGF-β2 effects on TM cells. RNA sequencing and cytokine analyses identified significant enrichment of HGF in TMSCs and TMSC-Scr. TMSC-Scr and HGF markedly reduced oxidative and fibrotic responses to TGF-β2 in TM cells, whereas an HGFI abolished this protective effect. CONCLUSIONS: Our findings confirm that TMSC-Scr and HGF are promising candidates for cell-free therapies in glaucoma. HGF confers intrinsic resilience in TMSCs and functions as a key, but partial, mediator of their protection of TM cells.
引用
- Du R, Yang E, Ayyala R, et al. Hepatocyte Growth Factor Confers Trabecular Meshwork Stem Cell Resilience and Paracrine Protection of Trabecular Meshwork Cells in Glaucoma. Invest Ophthalmol Vis Sci. 2026. PMID: 41920145. doi:10.1167/iovs.67.4.1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。